LTRN

Lantern Pharma Inc. is an artificial intelligence-driven oncology biotechnology company using machine learning and genomics to develop targeted cancer therapies. The company leverages its proprietary RADR AI platform to identify drug candidates and patient biomarkers for precision oncology treatments. Lantern is advancing multiple clinical programs targeting various cancer types with a focus on rescued drugs and novel combinations.